Fluid Biomed has raised $27 million to move forward with the development of its bioabsorbable stent designed to divert blood ...

With the introduction of self-expanding stents, an increased number of complex diseases were treated, with success rates comparable to those of open surgery. [14,15] In a contemporary study ...

The original prospective multicenter trial of the Palmaz stent included 486 patients. The mean luminal late loss was 15%, plus or minus 16%. Primary patency was 92%. Self-expanding stents The ...